Open AccessRelapsed NSCLC
Author(s) -
Michael Smith
Publication year - 2004
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000313234.00754.c1
Subject(s) - erlotinib , lung cancer , medicine , cancer , clinical trial , oncology , epidermal growth factor receptor